Diabetes

Saidal, Novo Nordisk Algeria sign agreement on production of innovative treatments

Wednesday, July 01, 2026 08:21
Diabetes: Saidal, Novo Nordisk Algeria sign agreement on production of innovative treatments

ALGIERS - Saidal Group signed a partnership agreement on Tuesday, in Algiers, with Novo Nordisk Algeria for the joint production and distribution of innovative molecules intended for the treatment of patients with diabetes and obesity, the group said in a statement.

Subscriber-Only Content

To continue reading this article, please sign in or subscribe.

Related articles